It’s astonishing to see a pharmaceutical giant growing its revenue at the rate of a technology startup. That’s what Eli Lilly https://www.reuters.com/markets/companies/LLY.N” target=”_blank” rel=”noopener”>(LLY.N) did in the second quarter, thanks to demand for…
Read More
About The Author
